Managing the patent thicket and maximizing patent lifetime in vaccine technology.
Patents are exclusive rights for a limited period of time that are granted to provide an incentive for innovation and in exchange for the public disclosure of an invention. Patenting in the medical field, especially in the field of human vaccine technologies, is full of pitfalls, because the products that finally access the market are often covered by a multitude of exclusive IP rights. This commentary gives an overview on obstacles in vaccine patenting and how to overcome them, and intends to provide a patenting guideline for researchers.
Kailuweit & Uhlemann Patent Attorneys, Dresden, Germany.
Maria M M
MM
Mertes
Gerd
G
Stötter
D006801:Humans; D010330:Patents as Topic; D013672:Technology / Q000331:legislation & jurisprudence*; D014612:Vaccines / Q000008:administration & dosage* / Q000276:immunology*
D014612:Vaccines